These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28906268)

  • 1. New PET markers for the diagnosis of dementia.
    Payoux P; Salabert AS
    Curr Opin Neurol; 2017 Dec; 30(6):608-616. PubMed ID: 28906268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus.
    Arbizu J; García-Ribas G; Carrió I; Garrastachu P; Martínez-Lage P; Molinuevo JL
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):303-13. PubMed ID: 26099942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.
    Brendel M; Schnabel J; Schönecker S; Wagner L; Brendel E; Meyer-Wilmes J; Unterrainer M; Schildan A; Patt M; Prix C; Ackl N; Catak C; Pogarell O; Levin J; Danek A; Buerger K; Bartenstein P; Barthel H; Sabri O; Rominger A
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2239-2248. PubMed ID: 28932894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain: positron emission tomography tracers beyond [¹⁸F]fluorodeoxyglucose.
    Singhal T; Alavi A; Kim CK
    PET Clin; 2014 Jul; 9(3):267-76. PubMed ID: 25030390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in Dementias.
    Mahalingam S; Chen MK
    Semin Neurol; 2019 Apr; 39(2):188-199. PubMed ID: 30925612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
    Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML
    Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic impact of [
    Zwan MD; Bouwman FH; Konijnenberg E; van der Flier WM; Lammertsma AA; Verhey FR; Aalten P; van Berckel BN; Scheltens P
    Alzheimers Res Ther; 2017 Jan; 9(1):2. PubMed ID: 28093088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current and future prospects of nuclear medicine in dementia].
    Ito K; Inui Y; Kizawa T; Kimura Y; Kato T
    Rinsho Shinkeigaku; 2017 Sep; 57(9):479-484. PubMed ID: 28804110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures.
    Grassetto G; Marzola MC; Musto A; Viniamury S; Colletti PM; Perkins AC; Rubello D
    Nucl Med Commun; 2014 Nov; 35(11):1085-92. PubMed ID: 25162962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.
    Bergeron D; Beauregard JM; Guimond J; Fortin MP; Houde M; Poulin S; Verret L; Bouchard RW; Laforce R
    J Alzheimers Dis; 2016; 49(3):695-705. PubMed ID: 26484904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT of Dementia.
    Zukotynski K; Kuo PH; Mikulis D; Rosa-Neto P; Strafella AP; Subramaniam RM; Black SE
    AJR Am J Roentgenol; 2018 Aug; 211(2):246-259. PubMed ID: 29949415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance for reading FDG PET scans in dementia patients.
    Herholz K
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):332-43. PubMed ID: 25391316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review.
    Rice L; Bisdas S
    Eur J Radiol; 2017 Sep; 94():16-24. PubMed ID: 28941755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease.
    Small GW
    J Geriatr Psychiatry Neurol; 2006 Sep; 19(3):180-5. PubMed ID: 16880360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.